SCHEMBL30272485

SCHEMBL30272485

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CPB2 Q96IY4 1/20 0.44
▸ ENPEP Q07075 7/20 0.44
▸ ALDH1A1 P00352 1/20 0.41
▸ F2 P00734 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31174186 0.89 CPB2 (0.47) CPB2ENPEPALDH1A1
SCHEMBL31174191 0.89 CPB2 (0.47) CPB2ENPEPALDH1A1
SCHEMBL31275692 0.88 ENPEP (0.46) CPB2ENPEPF2
SCHEMBL29782532 0.87 CPB2 (0.41) CPB2
SCHEMBL31276210 0.86 CPB2 (0.46) CPB2ENPEPALDH1A1F2
SCHEMBL23230150 0.86 ENPEP (0.51) ENPEPF2
SCHEMBL29603233 0.86 ENPEP (0.51) ENPEPF2
SCHEMBL29603899 0.86 ENPEP (0.51) ENPEPF2
SCHEMBL29455891 0.86 ENPEP (0.51) ENPEPF2
SCHEMBL21049253 0.86 GRIN2D (0.52) ENPEPF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11628202-B2 Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia NYMOX CORPORATION (CA) 2023-04-18 — — US disclosed
Send feedback